ClinicalTrials.Veeva

Menu

Predictors of the Metabolic Effect of Sleep Loss (SDBO)

The University of Chicago logo

The University of Chicago

Status

Completed

Conditions

Obstructive Sleep Apnea (OSA)
Apnea
Obesity

Treatments

Other: Extension
Other: Restriction

Study type

Interventional

Funder types

Other

Identifiers

NCT00965783
#15207A
1 RO1 IIL075025

Details and patient eligibility

About

To test whether baseline levels of slow wave activity (SWA) during sleep are lower in obese adults, and even lower in persons with sleep disordered breathing (SDB) compared to lean adults.

To compare levels of SWA in individuals in relation to their sleep time, blood pressure, heart rate, and markers of glucose metabolism.

Enrollment

30 patients

Sex

All

Ages

25 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy,
  • normal sleepers,
  • lean, overweight,
  • obese,
  • pre menopausal

Exclusion criteria

  • no shift workers or night-shift workers,
  • no mental health disorders,
  • no acute or chronic health conditions (stable, well controlled hypertension are accepted),
  • no hormonal treatments,
  • no substances that may interfere with sleep,
  • problems with sleep

Trial design

30 participants in 2 patient groups

1
Experimental group
Description:
Sleep time restriction
Treatment:
Other: Restriction
2
Experimental group
Description:
Sleep time extension
Treatment:
Other: Extension

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems